It is non-addictive and preserves the complete physiology of the sleep-wake cycle
Total semaglutide used in 4 weeks: 1mg
Two to three 60 mg vials cover the entire extended protocol with excellent cost efficiency
Common Side Effects When side effects occurred, they were typically mild, transient, and similar in frequency to placebo groups: Reported Adverse Effects Most Common (occurring in small percentage of participants): Mild to moderate headaches (most frequently reported, often resolving with continued use) Injection site reactions (minor redness, swelling, or irritation at injection site) Gastrointestinal effects (particularly at higher oral doses: mild nausea, diarrhea, flatulence) Fatigue (reported occasionally during initial adaptation period) Rare Events: One case of chest tightness was deemed possibly related to treatment in safety trials
Commonly reported mild effects in anecdotal community reports include nausea, fatigue, and injection site irritation
Research remains pre-clinical and investigational , focused on understanding molecular signaling behavior rather than clinical application